4//SEC Filing
Garfield Alastair 4
Accession 0001104659-24-078983
CIK 0001649904other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 5:01 PM ET
Size
8.4 KB
Accession
0001104659-24-078983
Insider Transaction Report
Form 4
Garfield Alastair
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2024-07-08+53,333→ 53,333 totalExercise: $43.76Exp: 2034-07-07→ Common Stock (53,333 underlying) - Award
Restricted Stock Units
2024-07-08+17,778→ 17,778 total→ Common Stock (17,778 underlying)
Footnotes (3)
- [F1]The options vest and become exercisable, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date, as to 6.25% of the total number of shares of common stock subject to the options upon the Reporting Person's completion of each successive three months of service to the Issuer after July 1, 2024, such that the option shall be fully vested and exercisable on July 1, 2028.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F3]The restricted stock units vest as to 25% of the total restricted stock units on each of the first four anniversaries of July 1, 2024, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0002027261
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 5:01 PM ET
- Size
- 8.4 KB